Waters Corporation introduced the Waters Biopharmaceutical System Solution, which brings together UPLC/MS characterization technology with UNIFI Scientific Information System, for a software solution that unites all aspects of biotherapeutic analyses and workflows for high-resolution analytics across the development process continuum.
The combination of UltraPerformance Liquid Chromatography, mass spectrometry, and bioinformatics technologies results in efficient flow of data and information and conforms to biopharmaceutical quality guidelines and regulations, according to the company.
The Biopharmaceutical System Solution includes the ACQUITY UPLC H-Class Bio System featuring a bio-inert flow path and quaternary solvent management with Auto-Blend Plus Technology; Waters Peptide and Protein Separation Technology Columns; Xevo G2 Tof Mass Spectrometer; and the UNIFI Scientific Information System, an interactive workflow-driven data platform for instrument control, data processing and mining and comprehensive reporting, and GxP laboratory compatibility.
Focused on task-specific workflow design, the Biopharmaceutical System features automated data processing and simplified results validation. Leveraging UNIFI’s architecture, the intuitive user interface can be configured for the roles and capabilities of the scientists throughout an organization. Critical to biopharmaceutical organizations is reliance on an analytical system that supports GMP and compliance tools, such as electronic signatures and user authentication, all with underlying secure database technology. The Biopharmaceutical System is scalable to use as a workstation with the ability to expand to workgroup and enterprise deployments.
